Search

Displaying results 7491 - 7500 of 7655 in total
  1. Drug

    NS-2359

    go.drugbank.com/drugs/DB05805
    Investigational

    NS2359 is a triple monoamine re-uptake inhibitor with a new, unique drug profile expected to yield important benefits compared to existing treatments of depression. Enhancing the function of the three neurotransmitters serotonin, noradre...

  2. Drug

    TAK-751S

    go.drugbank.com/drugs/DB06432
    Investigational

    TAK-751S is a synthetic analog of Shiga toxin (Stx) receptor, Gb3, produced by enterohemorrhagic Escherichia coli.

    Synonyms: Synsorb Pk, Synsorb-Pk
  3. Drug

    Minodronic acid

    go.drugbank.com/drugs/DB06548
    Investigational

  4. Drug

    RTN-001

    go.drugbank.com/drugs/DB05615
    Investigational

    SLx-2101 is an oral, long-acting PDE5 inhibitor developed by Surface Logix Inc. to treat Hypertension.

  5. Drug

    Bifeprunox

    go.drugbank.com/drugs/DB04888
    Investigational

    Bifeprunox is a novel atypical antipsychotic agent which, along with SLV313, aripiprazole and SSR-181507 combines minimal D2 receptor agonism with 5-HT receptor agonism.

  6. Drug

    Muparfostat

    go.drugbank.com/drugs/DB05808
    Investigational

    Muparfostat (PI-88) is a mixture of highly sulfated, monophosphorylated mannose oligosaccharides, derived from the extracellular phosphomannan of the yeast Pichia (Hansenula) holstii, with potential antiangiogenic activity.

  7. Drug

    Atiprimod

    go.drugbank.com/drugs/DB05513
    Investigational

  8. Drug

    Freselestat

    go.drugbank.com/drugs/DB03925
    Experimental

  9. Drug

    Fipamezole

    go.drugbank.com/drugs/DB06585
    Investigational

  10. Drug

    Aminoimidazole carboxamide

    go.drugbank.com/drugs/DB06143
    Investigational